Portal de Periódicos da CAPES

Successful management of chylous ascites after living donor liver transplantation with somatostatin

2007; Wiley; Volume: 28; Issue: 1 Linguagem: Inglês

10.1111/j.1478-3231.2007.01556.x

1478-3231

Hideki Ijichi, Yuji Soejima, Akinobu Taketomi, Tomoharu Yoshizumi, Hideaki Uchiyama, Noboru Harada, Yusuke Yonemura, Yoshihiko Maehara,

Vascular Malformations and Hemangiomas

Abstract Chylous ascites is a rare complication following liver transplantation. A variety of treatment options have been proposed for the management of chylous ascites; however, their effectiveness following a liver transplant is unknown. A 40‐year‐old woman who underwent living donor liver transplantation for primary biliary cirrhosis developed chylous ascites 21 days after the transplant. A conventional treatment consisting of a low‐fat diet with total parenteral nutrition failed to treat the complication for 104 days. However, the use of somatostatin in combination with total parenteral nutrition resulted in a rapid falloff in chyle output without any adverse effects. Somatostatin and total parenteral nutrition are an effective option for the treatment of chylous ascites after living donor liver transplantation.